Teiko Bio
Salt Lake City, United States · Founded 2020
- Headquarters
- Salt Lake City, Utah
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- teiko.bio
- Last Round
- SeedMar 2022
- Rounds
- 2
About
Immune-profiling cytometry platform for clinical trials.
Summary
Teiko Bio is a Biotech company based in Salt Lake City, United States, founded in 2020. Its most recent funding was a Seed round in Mar 2022. Investors include Founders Fund, TAU Ventures and Pathfinder Partners.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...